Ifosfamide seven-day infusion for recurrent and cisplatin refractory ovarian cancer.
Dorval T, Soussain C, Beuzeboc P, Garcia-Giralt E, Jouve M, Livartowski A, Mosseri V, Palangié T, Scholl S, Sastre X, Pouillart P.
Dorval T, et al. Among authors: beuzeboc p.
J Infus Chemother. 1996 Winter;6(1):47-9.
J Infus Chemother. 1996.
PMID: 8748008
Clinical Trial.